 Home > Medical News > Latest Medical News > Huahai Pharmaceutical's Nebivolol Tablets Obtained FDA Approval Number

Huahai Pharmaceutical's Nebivolol Tablets Obtained FDA Approval Number

 Last Update: 2022-05-24
 Source: Internet
 Author: User

Tags

capmatinib fda approval

nebivolol hcl

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 10, Huahai Pharmaceutical issued an announcement stating that it had received a notification from the US FDA that the company had submitted an abbreviated new drug application for nebivolol tablets to the US FDA (ANDA, that is, the US generic drug application, and the application was approved by the US FDA for review and approval).

Nebivolol tablets are mainly used to treat high blood pressure

Up to now, Huahai Pharmaceutical has invested approximately RMB 10.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.